Memorial Sloan-Kettering Cancer Center is a nonprofit organization that runs a cancer hospital in New York. The organization is based in New York, NY and managed by Harold E. Varmus. Its official home on the web is http://www.mskcc.org
NEW YORK (Reuters Health) - Important news for men with prostate cancer: first, the cancer tends to grow so slowly that only a fraction of patients actually die from it. Second, men with low-grade cancer who opt for close monitoring instead of surgery to remove the prostate do not seem to suffer anxiety and distress from living with ''untreated'' cancer. Those are the take-home messages of two studies appearing in medical journals this week. Prostate cancer, the second most common cancer in... Read Full Story
An influential doctors group is backing off its call for annual tests after age 50 to screen for prostate cancer. "Many men do not need yearly screening," but each man's risk should be individually assessed, said Dr. Peter Carroll, who led the panel that wrote the American Urological Association's new guidelines. They are being issued Monday at the group's annual meeting in Chicago. The new stance brings the group more in line with advice from other experts, who say annual screening is... Read Full Story
Women who carry mutations in the BRCA1 and BRCA2 genes have a dramatically increased risk of developing breast cancer: a 36 to 85 percent chance of developing the disease during their lifetime, which is three to five times greater than the average risk rate. Ken Offit, chief of the clinical genetics service at Memorial Sloan-Kettering Cancer Center, in New York, wants to know how the other 15 to 64 percent escape unscathed. Genetic microarrays that allow scientists to quickly screen the... Read Full Story
* Obama will state support for "scientific integrity" * Scientists hail decision * Religious conservatives unhappy By David Alexander WASHINGTON (Reuters) - President Barack Obama will
lift controversial restrictions on human stem cell research
Monday and sign a pledge to take politics out of science, the
White House says, a clear repudiation of the approach taken by
his predecessor George W. Bush. The decision, which fulfills a campaign promise, pits Obama
against many religious... Read Full Story
Early trials of a new drug for advanced prostate cancer are showing some success, researchers report. Of the first 30 patients treated with MDV3100, 13 showed declines of more than 50 percent in the levels of chemicals in the blood that indicate the presence of the cancer. However, the tests are only in phase 1 and 2, where drugs are checked for safety, side effects and early indications of effectiveness. The drug still faces a larger phase 3 tests of effectiveness before it can be proposed... Read Full Story
This is exciting news! I was just made aware of an article from Sloan Kettering on Zeolite. While it doesn't corroborate human anti-tumor it certainly DOES corroborate animal anti-tumor. This is HUMONGOUS!! Here's the excerpt and the link to the rest of the article. Mechanism of Action Zeolites have ion-exchanging and adsorption properties. Zeolite granules, when used externally on wounds, can stop bleeding and promote clotting through the absorption of water ( 2 ) ( 3 ) . Zeolites are... Read Full Story
Radiation May Help When Prostate Cancer Returns It halved the death rate and might need to be used more often, researchers say
By Ed Edelson HealthDay Reporter
TUESDAY, June 17 (HealthDay News) -- Countering common medical theory, a new study finds that radiation therapy may save the lives of many men whose prostate cancer recurs aggressively after surgery.
"We show that even men with aggressive disease that recurs after surgery seem to benefit from salvage radiotherapy," said... Read Full Story
Researchers express hope that finding will lead to treatments
Share
What is this?
Buzz
Digg
Facebook
More...
EMAIL
PRINT
RSS
FRIDAY, July 3 (HealthDay News) -- U.S. researchers say they've found a major cellular flaw that may drive the rapid spread of relapsed lung cancer.
When caught early, lung cancer can often be treated. But most cases are not detected until the disease is well advanced. Though doctors can... Read Full Story
Researchers at Memorial Sloan-Kettering Cancer Center (MSKCC), along with collaborating teams at the Cleveland Clinic and the University of Michigan, have completed a study of prostate cancer death after standard treatment to remove the prostate since PSA screening has become widely used as a method to screen for the disease.
Researchers found that in a group of 12,677 men who had radical prostatectomies between 1987 and 2005, the fifteen-year mortality rate that could be directly linked... Read Full Story
